Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 5, Issue 12, pp. 1271-1281
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 19, 2015
- Revision received September 24, 2015
- Accepted September 29, 2015
- Published first October 2, 2015.
Article Versions
- Previous version (October 2, 2015 - 06:07).
- Previous version (November 13, 2015 - 06:53).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Eunice L. Kwak1,2,*,
- Leanne G. Ahronian1,2,
- Giulia Siravegna3,4,
- Benedetta Mussolin3,4,
- Darrell R. Borger5,
- Jason T. Godfrey1,2,
- Nicholas A. Jessop5,
- Jeffrey W. Clark1,2,
- Lawrence S. Blaszkowsky1,2,
- David P. Ryan1,2,
- Jochen K. Lennerz5,
- A. John Iafrate5,
- Alberto Bardelli3,4,
- Theodore S. Hong1,6 and
- Ryan B. Corcoran1,2,*
- 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
- 2Department of Medicine, Harvard Medical School, Boston, Massachusetts.
- 3Department of Oncology, University of Torino, Torino, Italy.
- 4Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
- 5Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
- 6Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
- ↵*Corresponding Authors:
Ryan B. Corcoran, Massachusetts General Hospital Cancer Center, 149 13th Street, Boston, MA 02129. Phone: 617-726-8599; Fax: 617-643-0798; E-mail: rbcorcoran{at}partners.org; and Eunice L. Kwak, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114. Phone: 617-726-3252; Fax: 617-726-0452; E-mail: ekwak{at}partners.org
December 2015
Volume 5, Issue 12
Volume 5, Issue 12
Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer
Jump to section
Advertisement